Sameek Roychowdhury

7PUBLICATIONS
71CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 10, 2026
Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patients.

|Mar 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial.

Chunjie Li, Anne M Noonan, John Hays

|Sep 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.

Leah Stein, Karthikeyan Murugesan, Julie W Reeser

|Jan 09, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.

Emily L Hoskins, Eric Samorodnitsky, Michele R Wing

|Jun 17, 2022
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.

Mitchell L Ramsey, Jewel Tomlinson, Rachel Pearlman

|Dec 03, 2020
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.

Melanie A Krook, Julie W Reeser, Gabrielle Ernst

Pageof 2

Frequent Collaborators

2 joint publications

Pannaga Malalur

2 joint publications

Michele R Wing

2 joint publications

Ning Jin

2 joint publications

Karthikeyan Murugesan